|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Number of the document | 2870261 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13735529.3 |
| Date of filing the European patent application | 2013-06-26 | |
| (97) | Date of publication of the European application | 2015-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/047925 |
| Date | 2013-06-26 |
| (87) | Number | WO 2014/011398 |
| Date | 2014-01-16 |
| (30) | Number | Date | Country code |
| 201261669534 P | 2012-07-09 | US |
| (72) |
CAPONIGRO, Giordano, US
DELACH, Scott, US
GARRAWAY, Levi, US
JAGANI, Zainab, US
KIM, Sunkyu, US
KRYUKOV, Gregory, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215-5450, US Broad Institute, 44 Binney Street, Boston, Massachusetts 02115, US |
| (54) | BIOMARKERS ASSOCIATED WITH CDK INHIBITORS |
| BIOMARKERS ASSOCIATED WITH CDK INHIBITORS |